Disease | melanoma, malignant |
Comorbidity | C0023418|leukemia |
Sentences | 3 |
PubMedID- 25440434 | melanoma in patients with chronic lymphocytic leukemia and non-hodgkin lymphoma. |
PubMedID- 21559503 | Relatively high inhibitory activities by fe-sp treatment (gi50 less than 1.0×10−6 m) were achieved against all six leukemia cell lines, 4 of 7 melanoma cancer (lox imvi, malme-3m, sk-mel-28, uacc-62), 4 of 8 breast cancer (mcf-7, hs 578t, mda-mb-435, mda-mb-468), 1 of 2 prostate cancer (pc-3), 3 of 7 colon cancer (hct-116, km12, sw-620), 1 of 6 cns cancer (u251), 1 of 8 renal cancer (rxf 393) and 1 of 9 non-small cell lung cancer (nci-h522) cell lines. |
PubMedID- 20376794 | Objective: to analyze the expression level and clinical significance of the preferentially expressed antigen of melanoma (prame) transcripts in patients with acute myeloid leukemia (aml). |
Page: 1